Taurine 5 pp 453-461 | Cite as

Involvement of Nitric Oxide in Ischemia-Evoked Taurine Release in the Mouse Hippocampus

  • Pirjo Saransaari
  • Simo S. Oja
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 526)

Abstract

The novel type of neurotransmitter/neuromodulator nitric oxide (NO) is linked to the activation of the N-methyl-D-aspartate (NMDA) class of glutamate receptors and has been shown to modify transmitter release in the brain1. The synaptically released glutamate activates postsynaptic NMDA receptors and depolarizes the cell, allowing Ca2+to enter through the receptor-linked ion channels, activating the Ca2+-dependent enzyme, NO synthase (NOS)2. The NO formed may either act intercellularly or diffuse out of the cell and act extracellularly at the soluble guanylyl cyclase, enhancing the formation of 3’,5’-cyclic guanosine monophosphate (cGMP)3. NO affects neurotransmitter transport in different brain areas, e.g., by evoking the release of monoamines, GABA5 and glutamate6. On the other hand, inhibitory effects have been observed in dopamine7, GABA8 and glutamate release9, indicating that the actions of NO are apparently complex.

Keywords

Depression Ischemia Dopamine Cyanide NMDA 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schuman, E.R., and Madison, D.V., 1994, Nitric oxide and synaptic function.Annu. Rev. Neurosci.17:153–183.PubMedCrossRefGoogle Scholar
  2. 2.
    Bredt, S.D., Ferris, C.D., and Snyder, S.H., 1992, Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites.J. Biol. Chem.267:10976–10981.PubMedGoogle Scholar
  3. 3.
    Knowles, R.G., Palacios, M., Palmer, R.M.J., and Moncada, S., 1989, Formation of nitric oxide from L-arginine in the central nervous system: transduction mechanism for stimulation of the soluble guanylate cyclase.Proc. Natl. Acad. Sci. USA86:5159–5162.PubMedCrossRefGoogle Scholar
  4. 4.
    Kaehler, S.T., Singewald, N., Sinner, C., and Philippu, A., 1999, Nitric oxide modulates the release of serotonin in the rat hypothalamus.Brain Res.835:346–349.PubMedCrossRefGoogle Scholar
  5. 5.
    Ohkuma, S., Narihara, H., Katsura, M., Hasegawa, T., Kuriyama, K., 1995, Nitric oxide induced [3H]GABA release from cerebral cortical neurons is mediated by peroxynitrite.J. Neurochem.65:1109–1114.PubMedCrossRefGoogle Scholar
  6. 6.
    Segieth, J., Getting, S.J., Biggs, C.S., and Whitton, P.S., 1995, Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats.Neurosci. Lett.200:101–104.PubMedCrossRefGoogle Scholar
  7. 7.
    Guevara-Guzman, R., Emson, P.C., and Kendrick, K.M., 1994, Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP.J. Neurochem.62:807–810.PubMedCrossRefGoogle Scholar
  8. 8.
    .Getting, S.J., Segieth, J., Ahmad, S., Biggs, C.S., and Whitton, P.S., 1996, Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo.Brain Res.717:196-199. PubMedCrossRefGoogle Scholar
  9. 9.
    Kamisaki, Y., Maeda, K., Ishimura, M., Omura, H., Moriwaki, Y., and Itoh, T., 1994, NO enhancement by nitric oxide of glutamate release from P2 and P3 synaptosomes of rat hippocampus.Brain Res.644:128–134.PubMedCrossRefGoogle Scholar
  10. 10.
    Kontro, P., and Oja, S.S., 1987, Taurine and GABA release from mouse cerebral cortex slices: potassium stimulation releases more taurine than GABA from developing brain.Devi. Brain Res.37:277–291.CrossRefGoogle Scholar
  11. 11.
    Sturman, J. A., 1993, Taurine in developmentPhysiol. Rev.73:119–147.PubMedGoogle Scholar
  12. 12.
    Ooboshi, H., Sadoshima, S., Yao, H., Ibayashi, S., Matsumoto, T., Uchimura H., and Fujishima, M., 1995, Ischemia-induced release of amino acids in the rat hippocampus of aged hypertensive rats.J. Cereb. Blood Flow Metab.15:227–234.PubMedCrossRefGoogle Scholar
  13. 13.
    Saransaari, P., and Oja, S.S., 1997, Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus.Neuroscience79:847–854.PubMedCrossRefGoogle Scholar
  14. 14.
    Saransaari, P., and Oja, S.S., 1998, Mechanisms of ischemia induced taurine release in mouse hippocampal slices.Brain Res.807:118–124.PubMedCrossRefGoogle Scholar
  15. 15.
    Saransaari, P., and Oja, S.S., 1998, Release of endogenous glutamate, aspartate, GABA and taurine from hippocampal slices from adult and developing mice in cell-damaging conditions.Neurochem. Res.23:567–574.CrossRefGoogle Scholar
  16. 16.
    Saransaari, P. and Oja, S.S., 1999, Characteristics of ischemia-induced taurine release in the developing mouse hippocampus.Neuroscience94:949–954.PubMedCrossRefGoogle Scholar
  17. 17.
    Saransaari, P., and Oja, S.S., 2000, Taurine and neural cell damage.Amino Acids19:509526.Google Scholar
  18. 18.
    Saransaari, P., and Oja, S.S., 1999, Taurine release modified by nitric oxide-generating compounds in the developing and adult mouse hippocampus.Neuroscience89:1103–1111.PubMedCrossRefGoogle Scholar
  19. 19.
    DeMaster, E.G., Raij, L., Archer, S.L., and Weir, E.K., 1989, Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitricoxide. Biochem. Biophys. Res. Commun.163:527–533.PubMedCrossRefGoogle Scholar
  20. 20.
    Lei, S.Z., Pan, Z.-H., Aggarwal, S.K., Chen, H.-S. V., Hartman, J., Sucher, N.J., and Lipton, S.A., 1992, Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex.Neuron8:1087–1099.PubMedCrossRefGoogle Scholar
  21. 21.
    Saransaari, P., and Oja S.S., 2002, Ischemia-induced taurine release is modified by nitric oxide-generating compounds in slices from the developing and adult mouse hippocampus.Neurochem. Res.27, 395–402.CrossRefGoogle Scholar
  22. 22.
    Sorrenti, V., Di Giacomo, C., Campisi, A., Perez-Polo, J. R., and Vanella, A. 1999, Nitric oxide synthetase activity in cerebral post-ischemic reperfusion and effects of L-Nonitroarginine and 7-nitroindazole on the survival.Neurochem. Res.24:861–866.PubMedCrossRefGoogle Scholar
  23. 23.
    Garthwaite, J., Southam, E., Boulton, C.L., Nielsen, E.B., Schmidt, K., and Mayer, B., 1995, Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H[I,2,4joxadiazolo[4,3-ajquinoxalin-l -one.Molec. Pharmac.48:184–188.Google Scholar
  24. 24.
    Fedele, E., and Raiteri, M., 1999, In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway.Prog. Neurobiol.58:89–120.PubMedCrossRefGoogle Scholar
  25. 25.
    Boulton, C.L., Irving, A.J., Southam, E., Potier, B., Garthwaite, J., and Collingridge, G.L., 1994, The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices.Eur. J. Neurosci.6, 1528–1535.PubMedCrossRefGoogle Scholar
  26. 26.
    Sistiaga, A., Miras-Portugal, T., and S¨¢nchez-Prieto, J., 1997, Modulation of glutamate release by a nitric oxide/cyclic GMP-dependent pathway.Eur. J. Pharmac.321, 247–257.CrossRefGoogle Scholar
  27. 27.
    Sequeira, S.M., Carvalho, A.P., and Carvalho C.M., 1999, Both protein kinase G dependent and independent mechanisms are involved in the modulation of glutamate release by nitric oxide in rat hippocampal nerve terminals.Neurosci Len.261, 39–32.Google Scholar
  28. 28.
    Saransaari, P., and Oja S.S., 2002, Taurine release in the developing and adult mouse hippocampus: involvement of cyclic guanosine monophosphate.Neurochem Res.27, 1520.Google Scholar
  29. 29.
    Trabace, L., and Kendrick, K.M., 2000, Nitric oxide can differently modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation.J. Neurochem.75:1664–1674.PubMedCrossRefGoogle Scholar
  30. 30.
    Oja, S.S., and Saransaari, P., 2000, Modulation of taurine release by glutamate receptors and nitric oxide.Prog. Neurobiol.62:407–425.PubMedCrossRefGoogle Scholar
  31. 31.
    Saransaari, P., and Oja, S.S., 1997, Glutamate-agonist-evoked taurine release from the adult and developing mouse hippocampus in cell-damaging conditions.Amino Acids13:323–335.CrossRefGoogle Scholar
  32. 32.
    Garthwaite, J., 1991, Glutamate, nitric oxide and cell-cell signalling in the nervous system.Trends Neurosci.14:60–67.PubMedCrossRefGoogle Scholar
  33. 33.
    Manzoni, O., Prezeau, L., Marin, P., Deshanger, S., Bockaert, J., and Fagni, L., 1992, Nitric oxide-induced blockade of NMDA receptors.Neuron8:653–662.PubMedCrossRefGoogle Scholar
  34. 34.
    Omerovic, A., Leonard, J. P., and Kelso, S. R., 1994, Effects of nitroprusside and redox reagents on NMDA receptors expressed in Xenopus oocytes.Molec. Brain Res.22:89–96.PubMedCrossRefGoogle Scholar
  35. 35.
    Oh, S., and McCaslin, P.P., 1995, The iron component of sodium nitroprusside blocks NMDA-induced glutamate accumulation and intracellular Cal` elevation.Neurochem. Res.20:779–784.PubMedCrossRefGoogle Scholar
  36. 36.
    Scheller, D., Korte, M., Szathmary S., and Tegtmeier, F., 2000, Cerebral taurine release mechanisms in vivo: pharmacological investigations in rats using microdialysis for proof of principle.Neurochem. Res.25:801–807.PubMedCrossRefGoogle Scholar
  37. 37.
    Izumi, Y., Clifford, D.B., and Zorumski, C.F., 1992, Inhibition of long-term potentiation by NMDA-mediated nitric oxide release.Science257:1273–1276.PubMedCrossRefGoogle Scholar
  38. 38.
    Saransaari, P., and Oja, S.S., 2000, Involvement of metabotropic glutamate receptors in ischemi a-induced taurine release.Neurochem. Res.25:1067–1072.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Pirjo Saransaari
    • 1
  • Simo S. Oja
    • 1
    • 2
  1. 1.Tampere Brain Research Center, Medical SchoolUniversity of TampereFinland
  2. 2.Department of Clinical PhysiologyTampere University HospitalTampereFinland

Personalised recommendations